Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Molecular Oncology|July 4, 2026
From tumor-centric to ecosystem-based hypotheses in brain tumor research and care: Proceedings from The second Brain Tumor Meeting by the Sea organized by Julie Gavard and Eric Chevet, held in St Malo (France), 23-25 March 2026Julie Gavard, Flavie Bénard, Eva Billat, et al.The Journal of Pathology|February 1, 2014
Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic propertiesAnne Clavreul, Catherine Guette, Rogatien Faguer, et al.Oncology Letters|October 16, 2019
Extracellular AGR3 regulates breast cancer cells migration via Src signalingJoanna Obacz, Lucia Sommerova, Daria Sicari, et al.Journal of Cellular and Molecular Medicine|July 6, 2023
Endoplasmic reticulum homeostasis-From molecules to organisms: Report on the 14th International Calreticulin Workshop, Saint Malo, FranceKetsia Bakambamba, Federico Di Modugno, Marianne Guilbard, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 20, 2018
Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1Akram Obiedat, Einat Seidel, Mohamed Mahameed, et al.Journal of Neuro-Oncology|September 20, 2011
Isolation of a new cell population in the glioblastoma microenvironmentAnne Clavreul, Amandine Etcheverry, Agnès Chassevent, et al.Elife|May 31, 2016
Secretion of protein disulphide isomerase AGR2 confers tumorigenic propertiesDelphine Fessart, Charlotte Domblides, Tony Avril, et al.EMBO Reports|February 22, 2024
IRE1 RNase controls CD95-mediated cell deathDiana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, et al.Journal of Clinical Pharmacology|October 14, 2010
Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteersJoseph Kovalchin, Jeffrey Krieger, Kathy Collins, et al.Iscience|May 22, 2023
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatmentDiana Pelizzari-Raymundo, Dimitrios Doultsinos, Raphael Pineau, et al.Pageof 6